申请人:BASF Aktiengesellschaft
公开号:US05118685A1
公开(公告)日:1992-06-02
Aminopropanol derivatives of the formula: ##STR1## where R.sup.1 and R.sup.2 are identical or different and are each hydrogen, alkyl, cycloalkyl, alkenyl, alkynyl or hydroxyalkyl, each of not more than 6 carbon atoms, alkoxyalkyl, alkylthioalkyl or dialkylaminoalkyl, each of not more than 9 carbon atoms in total, or phenylalkyl or phenoxyalkyl where the alkyl radical is of not more than 6 carbon atoms and the phenyl radical is unsubstituted or substituted by alkyl or alkoxy, each of not more than 3 carbon atoms, or R.sup.1 and R.sup.2, together with the nitrogen atom which links them, form a 5-membered to 7-membered saturated heterocyclic ring which can be substituted by one or two phenyl and/or hydroxyl radicals and can contain an oxygen or nitrogen atom, as a further heteroatom in the ring, and such an additional nitrogen atom can be substituted by alkyl of 1 to 3 carbon atoms or by phenyl, and -- .circle.Het is thien-2-yl, thien-3-yl, pyrid-2-yl, pyrid-3-yl, pyrid-4-yl, fur-2-yl, 1-alkylpyrr-2-yl, 1-alkylpyrr-3-yl or 1-alkylpyrazol-4-yl, alkyl being of 1 to 3 carbon atoms, and their physiologically tolerated addition salts with acids, and antiarrhythmic agents containing these compounds.
化合物的氨基丙醇衍生物的化学式:##STR1## 其中R.sup.1和R.sup.2相同或不同,分别为氢,烷基,环烷基,烯基,炔基或羟基烷基,每个不超过6个碳原子,烷氧基烷基,烷硫基烷基或二烷基氨基烷基,每个总共不超过9个碳原子,或苯基烷基或苯氧基烷基,其中烷基基团不超过6个碳原子,苯基基团未取代或被烷基或烷氧基取代,每个不超过3个碳原子,或R.sup.1和R.sup.2与连接它们的氮原子一起形成一个5-成员至7-成员饱和杂环环,可以被一个或两个苯基和/或羟基基团取代,并且可以包含一个氧或氮原子作为环中的进一步杂原子,并且这样的额外氮原子可以被1至3个碳原子的烷基或苯基取代,-- .circle.Het是噻吩-2-基,噻吩-3-基,吡啶-2-基,吡啶-3-基,吡啶-4-基,呋喃-2-基,1-烷基吡咯-2-基,1-烷基吡咯-3-基或1-烷基吡唑-4-基,其中烷基为1至3个碳原子,以及它们与酸的生理耐受性加合物和含有这些化合物的抗心律失常药物。